Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is a commonly
performed procedure for pancreaticobiliary disease. While ERCP is highly effective, it is also …

Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is a technically
demanding procedure with a high risk for adverse events (AEs). Aim: evaluate patient-and …

Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is performed to
diagnose and manage conditions of the biliary and pancreatic ducts. Though effective, it is …

Objectives The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …

Endoscopic retrograde cholangiopancreatography (ERCP) has become a primary tool for
the treatment of biliary and pancreatic ductal diseases. It is essential for the endoscopist …

Endoscopic retrograde cholangiopancreatography (ERCP) is associated with a spectrum of
complications such as pancreatitis, hemorrhage, perforation, and cardiopulmonary events …

Post–endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is one of the
most common and feared adverse events related to endoscopic retrograde …

Background Although endoscopic retrograde cholangiopancreatography (ERCP) is a pivotal
procedure for the diagnosis and treatment of a variety of pancreatobiliary diseases, it has …

OBJECTIVES To provide health-care providers, patients, and physicians with an exhaustive
assessment of prospective studies on rates of complications and fatalities associated with …

Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or
indomethacin immediately before endoscopic retrograde cholangiopancreatography …